Jacques Gielen

4.4k total citations
100 papers, 3.8k citations indexed

About

Jacques Gielen is a scholar working on Molecular Biology, Pharmacology and Cancer Research. According to data from OpenAlex, Jacques Gielen has authored 100 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Biology, 33 papers in Pharmacology and 20 papers in Cancer Research. Recurrent topics in Jacques Gielen's work include Pharmacogenetics and Drug Metabolism (30 papers), Eicosanoids and Hypertension Pharmacology (14 papers) and Cholesterol and Lipid Metabolism (12 papers). Jacques Gielen is often cited by papers focused on Pharmacogenetics and Drug Metabolism (30 papers), Eicosanoids and Hypertension Pharmacology (14 papers) and Cholesterol and Lipid Metabolism (12 papers). Jacques Gielen collaborates with scholars based in Belgium, United States and France. Jacques Gielen's co-authors include Daniel W. Nebert, J. Van Cantfort, F.M. Goujon, Vincent Bours, Marie‐Paule Merville, Jean De Graeve, P. Kremers, Alain Chariot, Mohamed Bentires‐Alj and Nathalie Jacobs and has published in prestigious journals such as Science, Journal of Biological Chemistry and Journal of Molecular Biology.

In The Last Decade

Jacques Gielen

96 papers receiving 3.6k citations

Peers

Jacques Gielen
Michael E. McManus Australia
Susanna S.T. Lee United States
Gerard J. Mulder Netherlands
Raymond Novak United States
Mont R. Juchau United States
Nobuo Nemoto Japan
Burhan I. Ghanayem United States
H V Gelboin United States
Terry V. Zenser United States
Isabelle de Waziers France
Michael E. McManus Australia
Jacques Gielen
Citations per year, relative to Jacques Gielen Jacques Gielen (= 1×) peers Michael E. McManus

Countries citing papers authored by Jacques Gielen

Since Specialization
Citations

This map shows the geographic impact of Jacques Gielen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacques Gielen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacques Gielen more than expected).

Fields of papers citing papers by Jacques Gielen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacques Gielen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacques Gielen. The network helps show where Jacques Gielen may publish in the future.

Co-authorship network of co-authors of Jacques Gielen

This figure shows the co-authorship network connecting the top 25 collaborators of Jacques Gielen. A scholar is included among the top collaborators of Jacques Gielen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacques Gielen. Jacques Gielen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wildiers, Hans, et al.. (2009). Atropine, Hyoscine Butylbromide, or Scopolamine Are Equally Effective for the Treatment of Death Rattle in Terminal Care. Journal of Pain and Symptom Management. 38(1). 124–133. 61 indexed citations
2.
Marcelis, Machteld, Étienne Cavalier, Jacques Gielen, Philippe Delespaul, & Jim van Os. (2004). Abnormal response to metabolic stress in schizophrenia: marker of vulnerability or acquired sensitization?. Psychological Medicine. 34(6). 1103–1111. 39 indexed citations
3.
Delanaye, Pierre, Bernard Lambermont, Jean-Paul Chapelle, et al.. (2004). Plasmatic cystatin C for the estimation of glomerular filtration rate in intensive care units. Intensive Care Medicine. 30(5). 980–983. 72 indexed citations
4.
Viatour, Patrick, Sylvie Legrand-Poels, Carine Van Lint, et al.. (2003). Cytoplasmic IκBα Increases NF-κB-independent Transcription through Binding to Histone Deacetylase (HDAC) 1 and HDAC3. Journal of Biological Chemistry. 278(47). 46541–46548. 82 indexed citations
5.
Frédérich, Michel, Mohamed Bentires‐Alj, Monique Tits, et al.. (2003). Isostrychnopentamine, an Indolomonoterpenic Alkaloid from Strychnos usambarensis, Induces Cell Cycle Arrest and Apoptosis in Human Colon Cancer Cells. Journal of Pharmacology and Experimental Therapeutics. 304(3). 1103–1110. 17 indexed citations
6.
Chariot, Alain, Marie‐Alice Meuwis, Antonio Leonardi, et al.. (2003). NF-κB Activating Scaffold Proteins as Signaling Molecules and Putative Therapeutic Targets. Current Medicinal Chemistry. 10(7). 593–602. 12 indexed citations
7.
Fillet, Marianne, Mohamed Bentires‐Alj, Valérie Deregowski, et al.. (2003). Mechanisms involved in exogenous C2- and C6-ceramide-induced cancer cell toxicity. Biochemical Pharmacology. 65(10). 1633–1642. 55 indexed citations
8.
Bentires‐Alj, Mohamed, Anne‐Cecile Hellin, Chantal Lechanteur, et al.. (2000). Cytosine deaminase suicide gene therapy for peritoneal carcinomatosis. Cancer Gene Therapy. 7(1). 20–26. 24 indexed citations
9.
Princen, Frédéric, Chantal Lechanteur, Miguel Fraile‐López, et al.. (2000). Similar Efficiency of DNA-Liposome Complexes and Retrovirus-Producing Cells for HSV-tkSuicide Gene Therapy of Peritoneal Carcinomatosis. Journal of drug targeting. 8(2). 79–89. 9 indexed citations
10.
Chariot, Alain, et al.. (1999). CBP and histone deacetylase inhibition enhance the transactivation potential of the HOXB7 homeodomain-containing protein. Oncogene. 18(27). 4007–4014. 51 indexed citations
11.
Dejardin, Emmanuel, Valérie Deregowski, Nathalie Jacobs, et al.. (1999). Regulation of NF-κB activity by IκB-related proteins in adenocarcinoma cells. Oncogene. 18(16). 2567–2577. 98 indexed citations
12.
Chariot, Alain, Frédéric Princen, Jacques Gielen, et al.. (1999). IκB-α Enhances Transactivation by the HOXB7 Homeodomain-containing Protein. Journal of Biological Chemistry. 274(9). 5318–5325. 27 indexed citations
13.
Hellin, Anne‐Cecile, et al.. (1998). Nuclear factor – κB-dependent regulation of p53 gene expression induced by daunomycin genotoxic drug. Oncogene. 16(9). 1187–1195. 89 indexed citations
14.
Chariot, Alain & Jacques Gielen. (1998). Molecules in focus The HOXC6 homeodomain-containing proteins. The International Journal of Biochemistry & Cell Biology. 30(6). 651–655. 7 indexed citations
15.
Princen, Frédéric, Chantal Lechanteur, M. Lopez, et al.. (1998). Repeated cycles of retrovirus-mediated HSVtk gene transfer plus ganciclovir increase survival of rats with peritoneal carcinomatosis. Gene Therapy. 5(8). 1054–1060. 7 indexed citations
16.
Charlier, Corinne, Alain Chariot, Nadine Antoine, et al.. (1995). Tamoxifen and its active metabolite inhibit growth of estrogen receptor-negative MDA-MB-435 cells. Biochemical Pharmacology. 49(3). 351–358. 40 indexed citations
17.
Kremers, P., et al.. (1993). Repression of cytochrome P450 by cytokines: IL-1? counteracts clofibric acid induction of CYP4A in cultured fetal rat hepatocytes. Cell Biology and Toxicology. 9(3). 307–313. 18 indexed citations
18.
Cantfort, J. Van, Jean De Graeve, & Jacques Gielen. (1977). Radioactive assay for aryl hydrocarbon hydroxylase. Improved method and biological importance. Biochemical and Biophysical Research Communications. 79(2). 505–512. 248 indexed citations
19.
Cantfort, J. Van & Jacques Gielen. (1975). Cholesterol 7 α‐Hydroxylase. European Journal of Biochemistry. 55(1). 33–40. 39 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael E. McManus Breakdown of academic impact, for papers by Susanna S.T. Lee Breakdown of academic impact, for papers by Gerard J. Mulder Breakdown of academic impact, for papers by Raymond Novak Breakdown of academic impact, for papers by Mont R. Juchau Breakdown of academic impact, for papers by Nobuo Nemoto Breakdown of academic impact, for papers by Burhan I. Ghanayem Breakdown of academic impact, for papers by H V Gelboin Breakdown of academic impact, for papers by Terry V. Zenser Breakdown of academic impact, for papers by Isabelle de Waziers
Rankless by CCL
2026